| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:1.)
© 2003 American Heart Association, Inc.
In Memoriam |
University of Michigan Health System, Ann Arbor, Michigan
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
On November 8, 2002, at 62 years of age, Lennart Hansson lost a long battle with cancer. He died in the quiet dignity of his Stockholm home surrounded and supported by loved oneshis wife Gerd, his daughters, and stepdaughters. Len suffered his predicament with discipline and determination. He kept a full traveling schedule up to 3 weeks before his demise. Nobody listening to his recent lectures could have suspected that he had any personal cares or that he was coping with pain. And in the last week before his final hospitalization, Len took a cruise through the Mediterranean, willing himself to spend some quality time with his beloved wife.
| |||||||||||
His behavior in the last few weeks was typical of Lennart Hanssons entire life. He always could decide what was important, set his priorities, and focus his incredible energy on achieving specific goals. Luckily for all of us, the study of hypertension was the love of his scientific life. He left behind him an impressive opus that will continue to guide research into the treatment of hypertension for many years to come. For him, the treatment of hypertension was both an academic discipline and a practical problem. And as his curriculum vitae shows, he systematically prepared himself to master both sides of the issue.
Lennart Hansson was born on June 16, 1940 in Landskrona, Sweden. He graduated from Goteborg University Medical School in Goteborg, Sweden, where from 1968 to 1978, he was first a resident and later an instructor in medicine.
This article has been cited by other articles:
![]() |
M. F. Walter, R. F. Jacob, B. Jeffers, M. M. Ghadanfar, G. M. Preston, J. Buch, and R. P. Mason Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: A longitudinal analysis of the PREVENT study J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1996 - 2002. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |